Portland, ORNCT06133231Now EnrollingIRB Ready

Attention Deficit/Hyperactivity Disorder Clinical Trial in Portland, OR

Access cutting-edge attention deficit/hyperactivity disorder treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.

Sponsored by Oregon Health and Science University

Quick Self-Assessment

See if you qualify for this Portland location

Preparing your pre-screening questions…

Expert Care in Portland

Access attention deficit/hyperactivity disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related attention deficit/hyperactivity disorder treatment provided free

Apply for This Portland Location

Check if you qualify for this attention deficit/hyperactivity disorder clinical trial in Portland, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Portland

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Portland site if eligible
  4. 4Begin participation

About This Attention Deficit/Hyperactivity Disorder Study in Portland

Evaluate feasibility and acceptability of recruiting Black and Hispanic families for an open label clinical trial of multinutrients while collecting real-time parent-reported child behavior data and collecting at-home biospecimens to explore their potential as biomarkers, in a study of pediatric ADHD.

Sponsor: Oregon Health and Science University

Who Can Participate

Inclusion Criteria

Children, ages 6-17 years at enrollment, with suspected or definite ADHD based on parent report in a majority of families that identify as Black or Hispanic or multicultural
Meet criteria on Child and Adolescent Symptom Inventory-5 (CASI-5) ADHD scale (6+ symptoms ≥ 2), occurring in \>1 setting, plus one impairing irritability symptom (≥2) from Oppositional Defiant Disorder (ODD) or Disruptive Mood Dysregulation Disorder (DMDD) subscale
Able and willing to swallow up to 8 pills per day
Medication free for 2 weeks prior to baseline
Willing to use Tasso® OnDemand SST+ to collect blood at home and filter cards to provide urine samples
Able to communicate in English
Parent/care giver identifies child as Black/African American or Hispanic/Latina/o or more than one race (target 70-100%)

Exclusion Criteria

Neurological disorders
Medical conditions (e.g. cancer, kidney or liver disease, diabetes, hyperthyroidism)
Psychiatric conditions requiring hospitalization
Allergy to any supplement ingredient
In people with a uterus: sexually active, pregnancy or suspected pregnancy
Abnormality of mineral metabolism

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Portland?

Yes, this clinical trial (NCT06133231) has an active research site in Portland, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Attention Deficit/Hyperactivity Disorder Treatment Options in Portland, OR

If you're searching for attention deficit/hyperactivity disorder treatment options in Portland, OR, this clinical trial (NCT06133231) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced attention deficit/hyperactivity disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all attention deficit/hyperactivity disorder clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Portland, OR

See all pulmonary embolism clinical trials recruiting in Portland — not just this study.

Browse Pulmonary Embolism Trials in Portland

Ready to Join in Portland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Portland, OR